Use of prophylactic Saccharomyces boulardii to prevent Clostridium difficile infection in hospitalized patients: a controlled prospective intervention study

Antibiotic susceptibility of probiotic strains: Is it reasonable to combine probiotics with antibiotics?

(2017) C. Neut et al.   MEDECINE ET MALADIES INFECTIEUSES

Saccharomyces boulardiito prevent antibiotic-associated diarrhea: randomized, double-masked, placebo-controlled trial

(2016) Stephan Ehrhardt et al.   Open Forum Infectious Diseases

Systematic review with meta-analysis:Saccharomyces boulardiiin the prevention of antibiotic-associated diarrhoea

(2015) H. Szajewska et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): Revised Publication Guidelines from a Detailed Consensus Process

(2015) Greg Ogrinc et al.   Canadian Journal of Diabetes

Diagnostic Value of Run Chart Analysis: Using Likelihood Ratios to Compare Run Chart Rules on Simulated Data Series

(2015) Jacob Anhøj   PLoS One

A Multidisciplinary Intervention to Reduce Infections of ESBL- and AmpC-Producing, Gram-Negative Bacteria at a University Hospital

(2014) Jenny Dahl Knudsen et al.   PLoS One

Run Charts Revisited: A Simulation Study of Run Chart Rules for Detection of Non-Random Variation in Health Care Processes

(2014) Jacob Anhøj et al.   PLoS One

Probiotic actions on diseases: implications for therapeutic treatments

(2014) Yi-Heng Chiu et al.   Food & Function

Is primary prevention of Clostridium difficile infection possible with specific probiotics?

(2012) Stuart Johnson et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Economic healthcare costs of Clostridium difficile infection: a systematic review

(2010) S.S. Ghantoji et al.   JOURNAL OF HOSPITAL INFECTION

Systematic review and meta-analysis ofSaccharomyces boulardiiin adult patients

(2010) Lynne V McFarland   WORLD JOURNAL OF GASTROENTEROLOGY